Literature DB >> 28925613

Surgery versus monitoring and endocrine therapy for low-risk DCIS: The COMET Trial.

Linda M Youngwirth, Judy C Boughey, E Shelley Hwang.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28925613

Source DB:  PubMed          Journal:  Bull Am Coll Surg        ISSN： 0002-8045


× No keyword cloud information.
  17 in total

1.  The effect of treatment on patient-reported distress after breast cancer diagnosis.

Authors:  Oluwadamilola M Fayanju; Karine Yenokyan; Yi Ren; Benjamin A Goldstein; Ilona Stashko; Steve Power; Madeline J Thornton; P Kelly Marcom; E Shelley Hwang
Journal:  Cancer       Date:  2019-05-23       Impact factor: 6.860

2.  Incidence of Ductal Carcinoma In Situ in the United States, 2000-2014.

Authors:  Marc D Ryser; Laura H Hendrix; Mathias Worni; Yiling Liu; Terry Hyslop; E Shelley Hwang
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2019-06-11       Impact factor: 4.254

3.  The effect of an e-learning module on grading variation of (pre)malignant breast lesions.

Authors:  Carmen van Dooijeweert; Ivette A G Deckers; Emma J de Ruiter; Natalie D Ter Hoeve; Celien P H Vreuls; Elsken van der Wall; Paul J van Diest
Journal:  Mod Pathol       Date:  2020-05-13       Impact factor: 7.842

4.  Cancer Outcomes in DCIS Patients Without Locoregional Treatment.

Authors:  Marc D Ryser; Donald L Weaver; Fengmin Zhao; Mathias Worni; Lars J Grimm; Roman Gulati; Ruth Etzioni; Terry Hyslop; Sandra J Lee; E Shelley Hwang
Journal:  J Natl Cancer Inst       Date:  2019-09-01       Impact factor: 13.506

5.  Chronological Trends of Breast Ductal Carcinoma In Situ: Clinical, Radiologic, and Pathologic Perspectives.

Authors:  Si Eun Lee; Ha Yan Kim; Jung Hyun Yoon; Eun-Kyung Kim; Jee Ye Kim; Min Jung Kim; Ga Ram Kim; Youngjean Vivian Park; Hee Jung Moon
Journal:  Ann Surg Oncol       Date:  2021-07-01       Impact factor: 5.344

Review 6.  Clinical Trials for Ductal Carcinoma In Situ of the Breast.

Authors:  Michelle S Han; Seema A Khan
Journal:  J Mammary Gland Biol Neoplasia       Date:  2018-09-11       Impact factor: 2.673

7.  Treatment of Ductal Carcinoma in Situ: Considerations for Tailoring Therapy in the Contemporary Era.

Authors:  Anita Mamtani; Kimberly J Van Zee
Journal:  Curr Breast Cancer Rep       Date:  2020-02-24

8.  Clinicopathological predictors of postoperative upstaging to invasive ductal carcinoma (IDC) in patients preoperatively diagnosed with ductal carcinoma in situ (DCIS): a multi-institutional retrospective cohort study.

Authors:  Kiyo Tanaka; Norikazu Masuda; Naoki Hayashi; Yasuaki Sagara; Fumikata Hara; Takayuki Kadoya; Akira Matsui; Chieko Miyazaki; Tadahiko Shien; Eriko Tokunaga; Takako Hayashi; Naoki Niikura; Shigeto Maeda; Yoshihumi Komoike; Hiroko Bando; Chizuko Kanbayashi; Hiroji Iwata
Journal:  Breast Cancer       Date:  2021-02-18       Impact factor: 4.239

9.  Outcomes and Costs for Women After Breast Cancer: Preparing for Improved Survivorship of Medicare Beneficiaries.

Authors:  Arseniy P Yashkin; Rachel A Greenup; Galina Gorbunova; Igor Akushevich; Kevin C Oeffinger; E Shelley Hwang
Journal:  JCO Oncol Pract       Date:  2020-07-21

10.  Invasive breast cancer and breast cancer mortality after ductal carcinoma in situ in women attending for breast screening in England, 1988-2014: population based observational cohort study.

Authors:  Gurdeep S Mannu; Zhe Wang; John Broggio; Jackie Charman; Shan Cheung; Olive Kearins; David Dodwell; Sarah C Darby
Journal:  BMJ       Date:  2020-05-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.